Mint Med Review
Best for: Cost-sensitive buyers seeking flat $159/mo 'all doses' compounded GLP-1 pricing without per-tier escalation, with HSA/FSA payment + no-membership pay-as-you-go model + LegitScript verification + verbatim FDA disclaimer. Strong fit for self-pay patients in any of the 36 listed states who value pricing transparency + cancel-anytime over premium clinical features.
Mint Med (mintmed.com) is a national direct-to-consumer GLP-1 telehealth platform — **DISTINCT from the separately-listed Mint Medical Clinic** (mintmedicalclinic.com, Utah-only hybrid in-clinic + telehealth med spa under the Balance Medical Clinic parent). Mint Med is national, DTC-only, and significantly cheaper ($159/mo vs Mint Medical Clinic's $299/mo). Compounded semaglutide and compounded tirzepatide offered (both injection). Pricing: 'GLP-1 All Doses $159 per month' + promotional 'Use code 175NOW to get your First Six Weeks for only $175.' 'NO memberships' framing. Cancel anytime with 48 business-hour notice. HSA/FSA eligible. **36-state explicit coverage** (AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KS, KY, ME, MD, MI, MN, MT, NV, NH, NJ, NY, NC, ND, OH, OK, PA, TN, TX, UT, VT, VA, WA, WV, WI, WY) — site lists 35-state count but enumeration includes 36. LegitScript Certified ID **44490960** (verifiable). Verbatim FDA disclaimer: 'Compounded medications are created to meet individual patient needs and are not reviewed or approved by the FDA for safety or effectiveness. A valid prescription is required. Individual results may vary.' Asynchronous telehealth model in states that allow it. 'Board-certified Mint Med clinician' framing (no named individuals disclosed). All U.S.-based care team. NOT disclosed publicly: specific 503A/503B pharmacy partner name/address, named medical director, corporate legal entity (LLC/Inc/PC), governing law, arbitration venue. Live-verified 2026-05-20.
High confidence · Last verified 2026-05-20 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Mint Med is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Mint Med prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| All doses (standard monthly) | compounded | $159 |
| First Six Weeks promo (code 175NOW) | compounded | $117 |
| All doses (standard monthly) | compounded | $159 |
✓ Pros
- •**$159 'all doses' flat pricing** removes the typical DTC pattern of per-tier price escalation as patients titrate up — significantly more transparent vs competitors charging $99 starting then $200+ at higher doses
- •**No-membership model** — pay-as-you-go monthly with cancel-anytime + 48hr-notice — reduces sign-up friction
- •LegitScript Certified with publicly verifiable ID (44490960)
- •Verbatim FDA compounded-medication disclaimer published (meets WLR transparency standard)
- •36-state explicit list with full enumeration — strong coverage breadth
- •HSA/FSA eligible (uncommon in DTC compounded GLP-1)
- •Asynchronous telehealth in allowed states — faster intake vs synchronous-only competitors
- •Promotional code (175NOW) for First Six Weeks $175 = ~$117/mo effective — competitive intro tier
✗ Cons
- •**Distinct from Mint Medical Clinic (mintmedicalclinic.com, Utah-only hybrid med spa)** — buyers searching 'Mint' may confuse the two providers. Both are in the WLR directory but represent fundamentally different business models.
- •Specific 503A/503B pharmacy partner NOT named
- •503A vs 503B compounding designation NOT specified
- •Named medical director / clinical leadership NOT disclosed
- •Corporate legal entity (LLC/Inc/PC) NOT disclosed
- •Governing law / arbitration venue / corporate physical address NOT disclosed
- •Stated 35-state count vs enumerated 36-state list shows a minor inconsistency (one state appears double-counted or there's an off-by-one in the marketing copy)
- •Asynchronous telehealth model limits live-provider interaction in eligible states
Ready to start with Mint Med?
Starting at $117/month. See current pricing and start your free consultation.
Sources & methodology
Our Mint Med review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Mint Med
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Mint Med?
Starting at $117/month. See current pricing and start your free consultation.